rheumatology
Rheumatoid arthritis

Australian rheumatologists are rapid adopters of JAK inhibitors in RA

JAK inhibitors have been adopted with enthusiasm by Australian rheumatologists for the treatment of RA since they became available in 2015, according to figures from the OPAL (Optimising Patient outcomes in Australian rheumatoLogy) dataset. About one in four patients with RA are now starting on a JAK inhibitor as first line treatment, says Professor Geoff ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic